Evaluating the Clinical Efficacy of Thulio vs. Holmium Laser Enucleation of the Prostate

Status: Recruiting
Location: See location...
Intervention Type: Device
Study Type: Interventional
Study Phase: Not Applicable
SUMMARY

Many consider laser enucleation of the prostate the new 'gold standard' for the surgical treatment of benign prostatic hyperplasia (BPH) due to its excellent outcomes, high success rates, and long-term efficacy. Holmium laser enucleation of the prostate (HoLEP) was the earliest form of prostate enucleation and is recommended by the American Urological Association (AUA), along with thulium laser enucleation of the prostate (ThuLEP), as size-independent techniques for the management of BPH with fewer complications than transurethral resection of the prostate (TURP). Further development of laser technology has additionally led to enucleation using pulsed-modulated (e.g. Virtual Basket™ mode or MOSES™ mode) holmium lasers as well as the thulium fiber laser.

Eligibility
Participation Requirements
Sex: Male
Minimum Age: 18
Healthy Volunteers: t
View:

• Understand and voluntarily sign an informed consent form.

• Patients must be males with a prostate, at least 18 years of age

• No prior prostate surgery

Locations
United States
Ohio
Cleveland Clinic Main
RECRUITING
Cleveland
Contact Information
Primary
Iva Markovic
markovi@ccf.org
216-636-9694
Backup
Smita De, MD, PHD
des@ccf.org
216-445-4818
Time Frame
Start Date: 2025-06-02
Estimated Completion Date: 2026-09
Participants
Target number of participants: 50
Treatments
Active_comparator: Control - Holmium
Holmium laser enucleation
Experimental: Experimental - Thulio
Thulio laser enucleation
Related Therapeutic Areas
Sponsors
Leads: Smita De

This content was sourced from clinicaltrials.gov